Tech Company Financing Transactions
Melinta Therapeutics Funding Round
On 6/10/2015, Melinta Therapeutics received $67 million in funding from Malin, private investors and Vatera Healthcare Partners.
Transaction Overview
Company Name
Announced On
6/10/2015
Transaction Type
Venture Equity
Amount
$67,000,000
Round
Undisclosed
Investors
Malin (Lead Investor) (Sean Murphy)
Vatera Healthcare Partners (Thomas Koestler)
Proceeds Purpose
Proceeds from the financing will be used to complete the final Phase 3 study of delafloxacin, an investigational fluoroquinolone, currently undergoing a confirmatory Phase 3 study for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI). Funds will also support the potential submission of a New Drug Application (NDA) for delafloxacin for the lead indication, pursuing new indications for delafloxacin including hospital-treated community-acquired bacterial pneumonia (hCABP), and advancing a lead candidate for the company's ESKAPE pathogen program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 George St. 301
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
Melinta Therapeutics' mission is to discover, develop and commercialize groundbreaking antibiotics to overcome drug-resistant, life-threatening infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christine Miller
Chief Financial Officer
Peter Milligan
VP - Bus. Development
Michael McGuire
VP - Finance
Susan Blum
VP - General Counsel
Jennifer Sanfilippo
Browse more venture capital transactions:
Prev: 6/10/2015: Control venture capital transaction
Next: 6/10/2015: Rancher Labs venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs